Página principal > Resultados de la búsqueda: Cheng, Chun Yen
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
19 p, 537.2 KB Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis : Up to 5 years of follow-up in the DAYBREAK open-label extension trial / Cree, Bruce A. C (University of California) ; Selmaj, Krzysztof W. (University of Warmia and Mazury in Olsztyn) ; Steinman, Lawrence (Stanford University) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Hartung, Hans-Peter (Medical University of Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Sheffield, James K. (Bristol-Myers Squibb Company) ; Minton, Neil (Bristol-Myers Squibb Company) ; Cheng, Chun Yen (Bristol-Myers Squibb Company) ; Silva, Diego (Bristol-Myers Squibb Company) ; Kappos, Ludwig (University of Basel) ; Cohen, Jeffrey A. (Cleveland Clinic) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for treatment of relapsing forms of MS. Objective: To characterize long-term safety and efficacy of ozanimod. [...]
2022 - 10.1177/13524585221102584
Multiple sclerosis, Vol. 28 Núm. 12 (2022) , p. 1944-1962  
Registro completo - Creative Commons
2.
13 p, 374.2 KB A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP) / Horcajada, Juan Pablo (Institut Hospital del Mar d'Investigacions Mèdiques) ; Salata, Robert A. (Case Western Reserve University) ; Álvarez-Sala, Rodolfo (Hospital Universitario La Paz (Madrid)) ; Nitu, Floarea Mimi (Victor Babes Clinical Hospital of Infectious Diseases and Pneumophtisiology) ; Lawrence, Laura (Melinta Therapeutics) ; Quintas, Megan (Melinta Therapeutics) ; Cheng, Chun-Yen (Firma Clinical Research) ; Cammarata, Sue (Melinta Therapeutics) ; Universitat Autònoma de Barcelona. Departament de Medicina
The clinical and economic burden of community-acquired bacterial pneumonia (CABP) is significant and is anticipated to increase as the population ages and pathogens become more resistant. Delafloxacin is a fluoroquinolone antibiotic approved in the United States for the treatment of adults with acute bacterial skin and skin structure infections. [...]
2019 - 10.1093/ofid/ofz514
Open Forum Infectious Diseases, Vol. 7 (december 2019)  
Registro completo - Creative Commons

Vea también: autores con nombres similares
1 Cheng, C.
6 Cheng, C. H.
1 Cheng, C.Y.
4 Cheng, Ching-Yu
1 Cheng, Chun-Yen
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos